{"product_id":"meetings-by-mail-cleveland-clinic-2nd-annual-cleveland-clinic-cancer-conference-2026","title":"Meetings By Mail Cleveland Clinic 2nd Annual Cleveland Clinic Cancer Conference 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: medical oncologists, hematologists, radiation oncologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: 3\/2\/26\u003c\/p\u003e\n\u003cp\u003eThe 2nd Annual Cleveland Clinic Cancer Conference features the latest advances in the diagnosis and management of the most prevalent cancers at all stages of disease and treatment.  A world renowned faculty provide disease specific, evidence-based, practical presentations representing a variety of medical disciplines.  This includes current and future strategies for cancer care, while detailing the role of emerging technologies, support and non-pharmacologic therapeutics for the cancer patient.\u003c\/p\u003e\n\u003cp\u003eTopics include: Hematologic malignancies, myeloma, amyloidosis, tumor boards, genomics, precision oncology, lung cancer, palliative care, AI, novel therapies, gynecologic cancers, sarcoma, melanoma, GI cancers, breast cancer and much more.\u003c\/p\u003e\n\u003cp\u003eTheme: Innovations in Multidisciplinary Care.\u003c\/p\u003e\n\u003cp\u003eLocation: Margaritaville Hollywood Beach Resort, Hollywood, FL (and streaming via Meetings By Mail).\u003c\/p\u003e\n\u003cp\u003eTarget Audience: Medical oncologists, hematologists, radiation oncologists, and other oncology professionals.\u003c\/p\u003e\n\u003cp\u003eKey Topics: Hematological malignancies, genomics, precision oncology, AI in cancer care, gynecological cancers, sarcoma, and palliative care.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSession 1 – Updates and State of the Art Therapy in Hematologic Malignancies\u003c\/p\u003e\n\u003cp\u003eAdvances in the Management of Myeloproliferative Neoplasm\u003c\/p\u003e\n\u003cp\u003eYehuda Galili, MD\u003c\/p\u003e\n\u003cp\u003eRecent Advances in MDS and AML: What’s Practice Changing?\u003c\/p\u003e\n\u003cp\u003eAkriti Jain, MD\u003c\/p\u003e\n\u003cp\u003eAdvances in the Management of Myeloma\/AL Amyloidosis\u003c\/p\u003e\n\u003cp\u003eJack Khouri, MD\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eBetty Hamilton, MD; Alex Mejia Garcia, MD\u003c\/p\u003e\n\u003cp\u003eSession 2 – Genomics\/Precision Oncology\u003c\/p\u003e\n\u003cp\u003eGenetic Testing: What Oncologists Should Know\u003c\/p\u003e\n\u003cp\u003eSara Rhode, MS, CGC\u003c\/p\u003e\n\u003cp\u003eThe Future of AI in Cancer Care\u003c\/p\u003e\n\u003cp\u003eAli Zarrinpar, MD, PhD\u003c\/p\u003e\n\u003cp\u003eThe Power of Minimal Residual Disease Monitoring in Personalized Cancer Care\u003c\/p\u003e\n\u003cp\u003eShlomo Koyfman, MD\u003c\/p\u003e\n\u003cp\u003ePrecision Oncology Case Presentation and Panel Discussion\u003c\/p\u003e\n\u003cp\u003eJacob Miller, MD\u003c\/p\u003e\n\u003cp\u003eSession 3 – Updates and State of the Art Therapy in Lung Cancer\u003c\/p\u003e\n\u003cp\u003eSurgical Challenges After Neo-Adjuvant Therapy\u003c\/p\u003e\n\u003cp\u003eMonisha Sudarshan, MD, MPH\u003c\/p\u003e\n\u003cp\u003eTreatment of Early-Stage and Locally Advanced NSCLC\u003c\/p\u003e\n\u003cp\u003eSuresh S. Ramalingam, MD\u003c\/p\u003e\n\u003cp\u003eSpecial Issues in Managing Metastatic NSCLC\u003c\/p\u003e\n\u003cp\u003eKhaled Hassan, MD\u003c\/p\u003e\n\u003cp\u003eCurrent Management of Small Cell Lung Cancer\u003c\/p\u003e\n\u003cp\u003eLukas Delasos, DO\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eKhaled Hassan, MD; Diana Saravia, MD\u003c\/p\u003e\n\u003cp\u003eSession 4 – Key Issues in Palliative Care\u003c\/p\u003e\n\u003cp\u003eCancer Related Anorexia-Cachexia Syndrome and Cancer Related Fatigue: Evidence Based Management and Emerging Treatments\u003c\/p\u003e\n\u003cp\u003eNivia Ruiz, MD\u003c\/p\u003e\n\u003cp\u003eAcupuncture’s Role in Cancer-Related Symptom Management\u003c\/p\u003e\n\u003cp\u003eThuy Nguyen, DAOM, LAc\u003c\/p\u003e\n\u003cp\u003eBenzodiazepines: Friend or Foe?\u003c\/p\u003e\n\u003cp\u003eKaleena Chilcote, MD\u003c\/p\u003e\n\u003cp\u003eCancer Therapy-Induced Neuropathy Management\u003c\/p\u003e\n\u003cp\u003eRenato Samala, MD\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eLaura Shoemaker, DO\u003c\/p\u003e\n\u003cp\u003eSession 5 – Novel Therapies\u003c\/p\u003e\n\u003cp\u003eAntibody Drug Conjugate: Innocent Bystander?\u003c\/p\u003e\n\u003cp\u003eWen Wee Ma, MBBS\u003c\/p\u003e\n\u003cp\u003eCAR-T Cells and Cellular Therapy\u003c\/p\u003e\n\u003cp\u003ePaolo Caimi, MD\u003c\/p\u003e\n\u003cp\u003eInnovations in Anti-Cancer RNA Therapeutics\u003c\/p\u003e\n\u003cp\u003eNatalie Silver, MD\u003c\/p\u003e\n\u003cp\u003eWhen to Watch and Wait vs. Refer to Surgery: Best Practices for Defining cCR After TNT\u003c\/p\u003e\n\u003cp\u003eEmre Gorgun, MD\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eWen Wee Ma, MBBS; Natalie Silver, MD\u003c\/p\u003e\n\u003cp\u003eSession 6 – Updates and State of the Art Therapy in Selected Solid Tumors\u003c\/p\u003e\n\u003cp\u003eMultidisciplinary Management of Gynecologic Cancers\u003c\/p\u003e\n\u003cp\u003eRobert DeBernardo, MD\u003c\/p\u003e\n\u003cp\u003eDale Shepard, MD, PhD\u003c\/p\u003e\n\u003cp\u003eMelanoma\u003c\/p\u003e\n\u003cp\u003eJames Isaacs, MD\u003c\/p\u003e\n\u003cp\u003eState of the Art Therapy in Head\/Neck and Non-Melanoma Skin Cancers: Updates in Particle Therapy and Perioperative Immunotherapy\u003c\/p\u003e\n\u003cp\u003eJacob Miller, MD\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eRobert DeBernardo, MD; Sudha Amarnath, MD\u003c\/p\u003e\n\u003cp\u003eSession 7 – Updates and State of the Art Therapy in GI Cancers\u003c\/p\u003e\n\u003cp\u003eEarly-Onset Colorectal and Other GI Cancers: Implications for Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003eAlok Khorana, MD\u003c\/p\u003e\n\u003cp\u003eNovel Surgical Strategies in Colorectal Liver Metastases\u003c\/p\u003e\n\u003cp\u003eFederico Aucejo, MD\u003c\/p\u003e\n\u003cp\u003eShifting Treatment Paradigms in Gastro-Esophageal Cancers\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eMatthew Walsh, MD; Alok Khorana, MD\u003c\/p\u003e\n\u003cp\u003eSession 8 – Breast Cancer\u003c\/p\u003e\n\u003cp\u003eBreast Surgery Update\u003c\/p\u003e\n\u003cp\u003eStephen Grobmyer, MD\u003c\/p\u003e\n\u003cp\u003eBreast Radiation Oncology Updates\u003c\/p\u003e\n\u003cp\u003ePraveen Pendyala, MD\u003c\/p\u003e\n\u003cp\u003eAdvances in Adjuvant Therapy for Breast Cancer\u003c\/p\u003e\n\u003cp\u003eErin Roesch, MD\u003c\/p\u003e\n\u003cp\u003eLatest Updates on the Management of Metastatic Breast Cancer: Antibody -Drug Conjugates for Advanced Stage Disease\u003c\/p\u003e\n\u003cp\u003eRita Nanda, MD\u003c\/p\u003e\n\u003cp\u003eTumor Boards Case Panels\u003c\/p\u003e\n\u003cp\u003eMegan Kruse, MD; Stephen Grobmyer, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405750751428,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Cleveland-Clinic-2nd-Annual-Cleveland-Clinic-Cancer-Conference-2026.jpg?v=1784215634","url":"https:\/\/medicalcoursespro.com\/products\/meetings-by-mail-cleveland-clinic-2nd-annual-cleveland-clinic-cancer-conference-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}